Journal article
Getting the MOST out of follow-up: A randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer
PA Cohen, PM Webb, M King, A Obermair, V Gebski, P Butow, R Morton, W Lawson, P Yates, R Campbell, T Meniawy, M McMullen, A Dean, J Goh, O McNally, L Mileshkin, P Beale, R Beach, J Hill, C Dixon Show all
International Journal of Gynecological Cancer | Published : 2023
Abstract
Background: Physical symptoms, anxiety, depression, fear of recurrence, sexual dysfunction, and social withdrawal are common in women after treatment for ovarian cancer. Most patients would like and need help dealing with these symptoms. The traditional model of follow-up care is unstructured and largely focused on diagnosing recurrent disease, and most oncologists lack skills to identify and manage psychosocial issues. No high quality prospective clinical trials have been conducted to determine the optimal follow-up regimen or the cost effectiveness of ovarian cancer surveillance strategies. Primary Objective(s): To assess emotional wellbeing, acceptability, safety, and cost effectiveness o..
View full abstractGrants
Funding Acknowledgements
The study is funded by the Western Australia Health Translation Network's Health Service Translational Research Project Grant, the Australian Government's Medical Research Future Fund, the Australia and New Zealand Gynaecological Oncology Group (ANZGOG), and the Ladybird Foundation.